Ardena’s approach is to combine production of investigational medicinal products (IMPs) and (bio)sample collection kits at a single site.

This highly efficient strategy has a number of advantages. It allows us to supply combined product and (bio)sample collection kits in a single shipment, ensuring trial sites have the supplies they need to start generating high quality data as soon as possible.

Our approach also means our drug product and (bio)sample collection kit teams can work together in an efficient and responsive manner. In short, Ardena is unique in the sector by offering both CDMO and bioanalytical services in combination with the production and supply of (bio)sample collection kits.

Our clinical logistics capabilities include:

  • Team of five trained in IATA packing instructions
  • In house label printing and secondary packaging activities in dedicated rooms
  • Warehousing with temperature controlled storage areas, including a 2 – 8 °C area for primary and secondary packaged materials
  • Just in time labelling
  • QP release services